Stay Informed on Key Developments

Investor News and Updates

Bill_Ipad

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

21 - 30of 392 News
21 - 30of 392 News
May 30, 2024
Not intended for UK Media
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease cell therapy candidate bemdaneprocel
READ MORE
May 28, 2024
World Seed Congress 2024:
Bayer advances genome-editing initiatives for nutrition enhanced vegetables
READ MORE
May 16, 2024
Not intended for UK Media – Late-breaking data from pivotal Phase III studies OASIS 1 and 2 to be presented at 2024 ACOG Annual Meeting:
Elinzanetant significantly reduces frequency and severity of moderate to severe hot flashes associated with menopause
READ MORE
May 15, 2024
Not intended for U.S. and UK Media
Bayer starts Phase I study with novel targeted radionuclide therapy 225Ac-PSMA-Trillium in advanced metastatic prostate cancer
READ MORE
May 14, 2024
Bayer Group:
First-quarter performance as expected
READ MORE
May 08, 2024
Not intended for UK Media – The American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting 2024:
Bayer to unveil late-breaking data from Phase III OASIS 1 and 2 for elinzanetant in the treatment of vasomotor symptoms associated with menopause
READ MORE
April 26, 2024
CEO Bill Anderson at the Annual Stockholders’ Meeting:
“Restore trust and get Bayer on track for better performance”
READ MORE
April 16, 2024
Not intended for UK Media
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’s disease
READ MORE
March 19, 2024
Not intended for UK Media
Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer’s elinzanetant
READ MORE
March 05, 2024
Financial News Conference:
Bayer aims to enhance performance and regain strategic flexibility by 2026 – adjusted guidance for 2023 achieved
READ MORE
21 - 30of 392 News
21 - 30of 392 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more